E
HOOKIPA Pharma Inc.
HOOK
$0.825
-$0.0255-3.00%
E
Sell
10/10/2024Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 10/10/2024 due to a decline in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 10/10/2024 due to a decline in the volatility index and total return index.
D
Sell
9/24/2024Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 9/24/2024 due to an increase in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 9/24/2024 due to an increase in the volatility index.
E
Sell
9/5/2024Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index and total return index.
D
Sell
8/19/2024Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 8/19/2024 due to an increase in the volatility index and valuation index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 8/19/2024 due to an increase in the volatility index and valuation index.
E
Sell
7/31/2024Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 7/31/2024 due to a decline in the volatility index and valuation index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 7/31/2024 due to a decline in the volatility index and valuation index.
D
Sell
7/16/2024Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 7/16/2024 due to an increase in the volatility index and valuation index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 7/16/2024 due to an increase in the volatility index and valuation index.
E
Sell
6/26/2024Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 6/26/2024 due to a decline in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 6/26/2024 due to a decline in the volatility index and total return index.
D
Sell
6/11/2024Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 6/11/2024 due to an increase in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 6/11/2024 due to an increase in the volatility index and total return index.
E
Sell
5/24/2024Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index and valuation index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index and valuation index.
D
Sell
5/9/2024Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/9/2024 due to an increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.22 to 3.25.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/9/2024 due to an increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.22 to 3.25.
E
Sell
9/1/2023Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 9/1/2023 due to a decline in the total return index and volatility index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 9/1/2023 due to a decline in the total return index and volatility index.
D
Sell
8/17/2023Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 8/17/2023 due to a noticeable increase in the growth index, solvency index and volatility index. Debt to equity declined from 0.05 to 0.02, earnings per share increased from -$0.2725 to -$0.2178, and the quick ratio increased from 2.9 to 3.37.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 8/17/2023 due to a noticeable increase in the growth index, solvency index and volatility index. Debt to equity declined from 0.05 to 0.02, earnings per share increased from -$0.2725 to -$0.2178, and the quick ratio increased from 2.9 to 3.37.
E
Sell
7/28/2023Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index.
D
Sell
7/13/2023Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 7/13/2023 due to an increase in the total return index, volatility index and valuation index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 7/13/2023 due to an increase in the total return index, volatility index and valuation index.
E
Sell
5/23/2023Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 5/23/2023 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 121.68% from $13.14M to -$2.85M, EBIT declined 66.74% from -$13.59M to -$22.66M, and total revenue declined 59.43% from $7.83M to $3.18M.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 5/23/2023 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 121.68% from $13.14M to -$2.85M, EBIT declined 66.74% from -$13.59M to -$22.66M, and total revenue declined 59.43% from $7.83M to $3.18M.
D
Sell
5/15/2023Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/15/2023 due to a substantial increase in the growth index, volatility index and total return index. Total revenue increased 251.03% from $2.23M to $7.83M, operating cash flow increased 179.58% from -$16.51M to $13.14M, and EBIT increased 35.27% from -$20.99M to -$13.59M.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/15/2023 due to a substantial increase in the growth index, volatility index and total return index. Total revenue increased 251.03% from $2.23M to $7.83M, operating cash flow increased 179.58% from -$16.51M to $13.14M, and EBIT increased 35.27% from -$20.99M to -$13.59M.
E
Sell
3/14/2023Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 03/14/2023.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
11/21/2022Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 11/21/2022 due to a decline in the solvency index, growth index and total return index. Total revenue declined 18.79% from $2.75M to $2.23M, EBIT declined 13.93% from -$18.43M to -$20.99M, and earnings per share declined from -$0.2266 to -$0.2531.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 11/21/2022 due to a decline in the solvency index, growth index and total return index. Total revenue declined 18.79% from $2.75M to $2.23M, EBIT declined 13.93% from -$18.43M to -$20.99M, and earnings per share declined from -$0.2266 to -$0.2531.
D
Sell
8/3/2022Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 8/3/2022 due to an increase in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 8/3/2022 due to an increase in the volatility index and total return index.
D
Sell
7/19/2022Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 7/19/2022 due to a decline in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 7/19/2022 due to a decline in the volatility index.
D
Sell
6/22/2022Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 6/22/2022 due to an increase in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 6/22/2022 due to an increase in the volatility index and total return index.
D
Sell
6/3/2022Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 6/3/2022 due to a decline in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 6/3/2022 due to a decline in the volatility index.
D
Sell
5/18/2022Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 5/18/2022 due to an increase in the solvency index, growth index and volatility index. Operating cash flow increased 113.09% from -$13.24M to $1.73M, the quick ratio increased from 3.15 to 5.03, and earnings per share increased from -$0.65 to -$0.3989.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 5/18/2022 due to an increase in the solvency index, growth index and volatility index. Operating cash flow increased 113.09% from -$13.24M to $1.73M, the quick ratio increased from 3.15 to 5.03, and earnings per share increased from -$0.65 to -$0.3989.
D
Sell
5/5/2022Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 4/20/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 3.85 to 3.15, and debt to equity increased from 0.06 to 0.07.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D- on 4/20/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 3.85 to 3.15, and debt to equity increased from 0.06 to 0.07.
D
Sell
1/18/2022Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 1/18/2022 due to a decline in the volatility index and total return index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 1/18/2022 due to a decline in the volatility index and total return index.
D
Sell
1/3/2022Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 1/3/2022 due to an increase in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 1/3/2022 due to an increase in the volatility index.
D
Sell
12/16/2021Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 12/16/2021 due to a decline in the solvency index, growth index and volatility index. Total revenue declined 27.97% from $5.38M to $3.87M, debt to equity increased from 0.05 to 0.06, and earnings per share declined from -$0.5229 to -$0.61.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D- from D on 12/16/2021 due to a decline in the solvency index, growth index and volatility index. Total revenue declined 27.97% from $5.38M to $3.87M, debt to equity increased from 0.05 to 0.06, and earnings per share declined from -$0.5229 to -$0.61.
D
Sell
11/9/2021Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D on 11/8/2021 due to a major decline in the total return index, volatility index and growth index. Operating cash flow declined 44% from -$14.4M to -$20.73M, and EBIT declined 0.61% from -$19.17M to -$19.29M.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E+ from D on 11/8/2021 due to a major decline in the total return index, volatility index and growth index. Operating cash flow declined 44% from -$14.4M to -$20.73M, and EBIT declined 0.61% from -$19.17M to -$19.29M.
D
Sell
7/16/2021Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D from D+ on 7/16/2021 due to a large decline in the growth index, solvency index and volatility index. Operating cash flow declined 27.4% from -$11.3M to -$14.4M, EBIT declined 26.18% from -$15.19M to -$19.17M, and debt to equity increased from 0.04 to 0.05.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D from D+ on 7/16/2021 due to a large decline in the growth index, solvency index and volatility index. Operating cash flow declined 27.4% from -$11.3M to -$14.4M, EBIT declined 26.18% from -$15.19M to -$19.17M, and debt to equity increased from 0.04 to 0.05.
D
Sell
3/19/2021Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D+ from D on 3/19/2021 due to a large increase in the growth index, solvency index and volatility index. The quick ratio increased from 5.24 to 7.73, debt to equity declined from 0.07 to 0.04, and total revenue increased 27.8% from $4.04M to $5.16M.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D+ from D on 3/19/2021 due to a large increase in the growth index, solvency index and volatility index. The quick ratio increased from 5.24 to 7.73, debt to equity declined from 0.07 to 0.04, and total revenue increased 27.8% from $4.04M to $5.16M.
D
Sell
1/11/2021Downgrade
HOOKIPA Pharma Inc. (HOOK) was downgraded to D from D+ on 1/11/2021 due to a decline in the total return index.
HOOKIPA Pharma Inc. (HOOK) was downgraded to D from D+ on 1/11/2021 due to a decline in the total return index.
D
Sell
12/15/2020Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D+ from D on 12/15/2020 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 1.71% from -$10.55M to -$10.37M.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D+ from D on 12/15/2020 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 1.71% from -$10.55M to -$10.37M.
D
Sell
5/1/2020Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index and solvency index. Total revenue increased 77.53% from $2.04M to $3.62M, earnings per share increased from -$0.4481 to -$0.4028, and operating cash flow increased 7.3% from -$9.49M to -$8.79M.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index and solvency index. Total revenue increased 77.53% from $2.04M to $3.62M, earnings per share increased from -$0.4481 to -$0.4028, and operating cash flow increased 7.3% from -$9.49M to -$8.79M.
D
Sell
1/2/2020Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 1/2/2020 due to an increase in the total return index.
HOOKIPA Pharma Inc. (HOOK) was upgraded to D- from E+ on 1/2/2020 due to an increase in the total return index.
E
Sell
12/23/2019Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to E+ from E on 12/23/2019 due to a noticeable increase in the volatility index, total return index and growth index. Earnings per share increased from -$0.6278 to -$0.4481, operating cash flow increased 16.78% from -$11.4M to -$9.49M, and EBIT increased 0.39% from -$13.63M to -$13.58M.
HOOKIPA Pharma Inc. (HOOK) was upgraded to E+ from E on 12/23/2019 due to a noticeable increase in the volatility index, total return index and growth index. Earnings per share increased from -$0.6278 to -$0.4481, operating cash flow increased 16.78% from -$11.4M to -$9.49M, and EBIT increased 0.39% from -$13.63M to -$13.58M.
E
Sell
10/1/2019Upgraded
HOOKIPA Pharma Inc. (HOOK) was upgraded to E from E- on 10/1/2019 due to a substantial increase in the solvency index, growth index and total return index. Earnings per share increased from -$9.2679 to -$0.6278, total revenue increased 81.25% from $2.24M to $4.05M, and the quick ratio increased from 4.76 to 7.95.
HOOKIPA Pharma Inc. (HOOK) was upgraded to E from E- on 10/1/2019 due to a substantial increase in the solvency index, growth index and total return index. Earnings per share increased from -$9.2679 to -$0.6278, total revenue increased 81.25% from $2.24M to $4.05M, and the quick ratio increased from 4.76 to 7.95.
E
Sell
7/15/2019None
HOOKIPA Pharma Inc. (HOOK) was downgraded to E- from U on 07/15/2019.
HOOKIPA Pharma Inc. (HOOK) was downgraded to E- from U on 07/15/2019.
NASDAQ
04/04/2025 4:00PM Eastern
Quotes delayed
